WeLeader Biomedical Co Stock

WeLeader Biomedical Co P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of WeLeader Biomedical Co (7713.TWO) as of Aug 16, 2026 is 32.43. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was 30.90 — a change of 4.97% (higher).

P/FCF

32.43

YoY

4.97%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of WeLeader Biomedical Co is 2026 32.43 . P/FCF (Price-to-Free-Cash-Flow Ratio) of WeLeader Biomedical Co was 2025 30.90 . It decreases by 4.97% higher compared to the previous year.
Access this data via the Eulerpool API

WeLeader Biomedical Co Stock analysis

What does WeLeader Biomedical Co do? WeLeader Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about WeLeader Biomedical Co stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of WeLeader Biomedical Co is 32.43 in 2026.

P/FCF (Price-to-Free-Cash-Flow Ratio) of WeLeader Biomedical Co changed from 30.90 to 32.43, representing a 4.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) WeLeader Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s WeLeader Biomedical Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — WeLeader Biomedical Co

All Key Metrics — WeLeader Biomedical Co